CLAUSE · BACKTEST REPORT · HYPOTHETICAL PERFORMANCE
Kelly's calm giants
“each month hold the 5 lowest-volatility names among AAPL MSFT NVDA GOOGL AMZN META AVGO COST V JNJ with half-kelly sizing”
Tested over October 2014 to October 2026. On data sealed Oct 15, 2026. Published 15 October 2026.
The contract
- 1. Universe. Trade only AAPL, MSFT, NVDA, GOOGL, AMZN, META, AVGO, COST, V, JNJ.
- 2. Signal. On the first trading day of each month at 09:35 ET, read each universe member’s 63-day realized volatility.
- 3. Rebalance. Rebalance into the bottom 5 of the universe by 63-day realized volatility, sized by 0.5x Kelly on a 126-day lookback.
Equity vs SPY, dividends reinvested
Tear sheet
TOTAL
+811%
CAGR
+20.2%
VOL
18.9%
SHARPE
0.98
SPY SHARPE
0.76
BUY-AND-HOLD SHARPE
1.03
SORTINO
1.38
MAX DD
−29.6%
LONGEST DD
622 days
BETA
0.85
GROSS
96.2%
GROSS MAX
100%
NET
+96.2%
LONG
97.2%
SHORT
0.0%
TRADES
579
TURNOVER
311%
COST DRAG
0.3%
CAPACITY
$7,689,737 (AVGO)
FINAL VALUE
$910,883 from $100,000
Per-clause attribution
What each clause earned while its decision governed the portfolio, holds included; these add up to the total return. The second figure re-runs the backtest with that clause removed and shows how the result would change.
About these numbers
Window
Fills
Borrow
Every short pays 0.3% a year on the value of the position for each calendar day it is held. Where our data carries short interest, the rate steps up with short interest as a percent of shares outstanding, using the figure that was public before each session.
An assumption, not a record: we hold no historical borrow rates.
| Short interest | Borrow |
|---|---|
| 20% of shares outstanding or more | 12% a year |
| 10% of shares outstanding or more | 4% a year |
| 5% of shares outstanding or more | 1.5% a year |
| under 5%, or none on file | 0.3% a year |
Dividends
Margin
Delistings
Halts
Attribution
Hypothetical performance on historical data. The same contract on the same data and cost model reproduces this number exactly. Backtests are not indicative of future results.